AVANT Immunotherapeutics About
Avant Immunotherapeutics: AVANT Immunotherapeutics, Inc.
is engaged in the discovery, development and commercialization of products that
harness the human immune system to prevent and treat disease. AVANT is developing
a broad portfolio of vaccines and immunotherapeutics addressing a wide range of
applications including bacterial and viral diseases, cardiovascular diseases,
biodefense and food safety. These include single dose, oral vaccines that protect
against important disease causing agents, a novel, proprietary vaccine candidate
for cholesterol management, and an immunotherapeutic to improve patient outcomes
after cardiac surgery. Their strategy is to demonstrate proof of concept for their
products before leveraging their value through partnerships. Pipeline
Chart for Avant Immunotherapeutics Pipeline: Key
Statistics fo
Avant
Phase
II TP10
Cardiac
Surgery Phase
II CETi-I
Cholesterol
Management Phase
II CholeraGarde
Cholera
Phase
II Ty800
Typhoid
Fever Phase
I Injectable
Anthrax Anthrax
Phase
I Therapore HIV
More on Avant:
Basic Chart
for Avant